[Unilateral combined strabismus surgery to correct esotropia : Video article on recession of the medial rectus muscle and plication of the lateral rectus muscle]. / Einseitige kombinierte Augenmuskeloperation zur Korrektur der Esotropie : Videobeitrag zur Rücklagerung des M. rectus medialis und Faltung des M. rectus lateralis.

OBJECTIVE OF SURGERY: The aim of strabismus surgery to correct esotropia is orthotropic alignment or microstrabismus to achieve best possible binocularity, a larger visual field, better appearance, and a frequently connected improved self-esteem. A widely used technique to correct esotropia is combined unilateral strabismus surgery with recession of the medial rectus muscle and plication of the lateral rectus muscle. INDICATIONS: Indications are esotropia of various origins or decompensating esophoria over 15 prism diopters. CONTRAINDICATIONS: Absolute contraindications are insufficient optical correction of hyperopia and sixth nerve palsy with unfinished spontaneous regeneration. A relative contraindication in children is untreated amblyopia. SURGICAL TECHNIQUE: The technique consists of unilateral recession of the medial rectus muscle and tucking of the lateral rectus muscle. The surgical technique is demonstrated in detail in two videos of the operation, which are available online. FOLLOW-UP: Antibiotic and lubricating eye drops are applied during the first week after surgery. In the early postoperative period, patients should be monitored for postoperative infection, conjunctival dehiscence, or corneal laceration. We review patients 4 months postoperatively for evaluation of the long-term result. EVIDENCE: Recent randomized controlled studies have shown that unilateral medial rectus muscle recession and resection surgery is comparable to bilateral recession surgery with regards to postoperative results in esotropia. The effect of lateral rectus muscle tuck is comparable to muscle resection with less trauma and potential reversibility during the first days after surgery.

[Tear in the retinal pigment epithelium by intravitreal injection of aflibercept]. / Riss des retinalen Pigmentepithels durch intravitreale Aflibercept-Injektion.

Development of tears in the retinal pigment epithelium (RIP) has been described as a possible complication following anti-vascular endothelial growth factor (VEGF) antibody therapy with substances which have been available for years when treating pigment epithelium detachment (PED) in eyes affected by age-related macular degeneration (AMD). Aflibercept has become available for the treatment of exsudative AMD since December 2012. This case report describes a further patient in addition to the only other case published so far who developed RIP after aflibercept treatment for PED. Patients have to be thoroughly informed about this potential side effect before initiation of intravitreal aflibercept injection therapy.